Amarin Corp Plc (AMRN)

[Hike]

At end of call. Something to look forward to.

"After we get through the approval in the U.S., we’ve got a very talented R&D team who will research some of the ideas that they’ve – that they’ve halted in the past. Then we’ll come back with some communication as to what we’re going to be working on next, but right now, there is nothing larger that we could be working on than what we’re doing with Vascepa, and we want to ensure that we provide, that’s the appropriate focus. So we’ll get back to you in the future relative to what we might be working on beyond Vascepa. But Vascepa is pretty big. So let’s get that right."